These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
334 related articles for article (PubMed ID: 35436972)
1. The role of m6A methylation in osteosarcoma biological processes and its potential clinical value. Wu Y; Wang Z; Shen J; Yan W; Xiang S; Liu H; Huang W Hum Genomics; 2022 Apr; 16(1):12. PubMed ID: 35436972 [TBL] [Abstract][Full Text] [Related]
2. Methylation recognition protein YTH N6-methyladenosine RNA binding protein 1 (YTHDF1) regulates the proliferation, migration and invasion of osteosarcoma by regulating m6A level of CCR4-NOT transcription complex subunit 7 (CNOT7). Wei K; Gao Y; Wang B; Qu YX Bioengineered; 2022 Mar; 13(3):5236-5250. PubMed ID: 35156522 [TBL] [Abstract][Full Text] [Related]
3. Potential role of m6A RNA methylation regulators in osteosarcoma and its clinical prognostic value. Liu H; Qin G; Ji Y; Wang X; Bao H; Guan X; Wei A; Cai Z J Orthop Surg Res; 2021 May; 16(1):294. PubMed ID: 33952279 [TBL] [Abstract][Full Text] [Related]
4. The m6A methyltransferase METTL3 promotes osteosarcoma progression by regulating the m6A level of LEF1. Miao W; Chen J; Jia L; Ma J; Song D Biochem Biophys Res Commun; 2019 Aug; 516(3):719-725. PubMed ID: 31253399 [TBL] [Abstract][Full Text] [Related]
5. N6-methyladenosine (m6A) modification in osteosarcoma: expression, function and interaction with noncoding RNAs - an updated review. Zhang Y; Xu Y; Bao Y; Luo Y; Qiu G; He M; Lu J; Xu J; Chen B; Wang Y Epigenetics; 2023 Dec; 18(1):2260213. PubMed ID: 37766615 [TBL] [Abstract][Full Text] [Related]
6. N6-methyladenosine Modification-Related Long Non-Coding RNAs are Potential Biomarkers for Predicting the Prognosis of Patients With Osteosarcoma. Yang K; Wang F; Li K; Peng G; Yang H; Xu H; Xiang Y; Sun H Technol Cancer Res Treat; 2022; 21():15330338221085354. PubMed ID: 35422168 [No Abstract] [Full Text] [Related]
7. Integrated analysis of transcriptome-wide m Wang Y; Zeng L; Liang C; Zan R; Ji W; Zhang Z; Wei Y; Tu S; Dong Y Epigenomics; 2019 Nov; 11(15):1693-1715. PubMed ID: 31650864 [No Abstract] [Full Text] [Related]
8. ALKBH5 regulates STAT3 activity to affect the proliferation and tumorigenicity of osteosarcoma via an m6A-YTHDF2-dependent manner. Yang Z; Cai Z; Yang C; Luo Z; Bao X EBioMedicine; 2022 Jun; 80():104019. PubMed ID: 35490460 [TBL] [Abstract][Full Text] [Related]
9. RNA m6A modifications in mammalian gametogenesis and pregnancy. Sui X; Klungland A; Gao L Reproduction; 2023 Jan; 165(1):R1-R8. PubMed ID: 36194446 [TBL] [Abstract][Full Text] [Related]
10. m6A-dependent up-regulation of DRG1 by METTL3 and ELAVL1 promotes growth, migration, and colony formation in osteosarcoma. Ling Z; Chen L; Zhao J Biosci Rep; 2020 Apr; 40(4):. PubMed ID: 32266933 [TBL] [Abstract][Full Text] [Related]
11. METTL14-mediated epitranscriptome modification of MN1 mRNA promote tumorigenicity and all-trans-retinoic acid resistance in osteosarcoma. Li HB; Huang G; Tu J; Lv DM; Jin QL; Chen JK; Zou YT; Lee DF; Shen JN; Xie XB EBioMedicine; 2022 Aug; 82():104142. PubMed ID: 35810559 [TBL] [Abstract][Full Text] [Related]
12. Transcriptome-wide profiling identifies colon cancer-associated m6A transcripts and potential RNA methyl modifiers. Ramasamy D; Thippannah M; Maharajan HRP; Balaiah M; Seshadri RA; Kodous AS; Herceg Z; Mehta A; Rao AKDM; Mani S Mol Biol Rep; 2024 Feb; 51(1):299. PubMed ID: 38345740 [TBL] [Abstract][Full Text] [Related]
13. Role of m6A methylation in retinal diseases. Zhu X; Zhou C; Zhao S; Zheng Z Exp Eye Res; 2023 Jun; 231():109489. PubMed ID: 37084873 [TBL] [Abstract][Full Text] [Related]
14. Identification of N6-methylandenosine related LncRNAs biomarkers associated with the overall survival of osteosarcoma. Zhang P; Xu K; Wang J; Zhang J; Quan H BMC Cancer; 2021 Dec; 21(1):1285. PubMed ID: 34852770 [TBL] [Abstract][Full Text] [Related]
15. Novel insights into the interaction between N6-methyladenosine methylation and noncoding RNAs in musculoskeletal disorders. Han J; Kong H; Wang X; Zhang XA Cell Prolif; 2022 Oct; 55(10):e13294. PubMed ID: 35735243 [TBL] [Abstract][Full Text] [Related]
16. The Emerging Role of RNA N6-Methyladenosine Modification in Pancreatic Cancer. Hu X; Lei X; Guo J; Fu W; Sun W; Lu Q; Su W; Xu Q; Tu K Front Oncol; 2022; 12():927640. PubMed ID: 35936737 [TBL] [Abstract][Full Text] [Related]
17. N6-methyladenosine (m6A) methylation in kidney diseases: Mechanisms and therapeutic potential. Sun Y; Jin D; Zhang Z; Ji H; An X; Zhang Y; Yang C; Sun W; Zhang Y; Duan Y; Kang X; Jiang L; Zhao X; Lian F Biochim Biophys Acta Gene Regul Mech; 2023 Dec; 1866(4):194967. PubMed ID: 37553065 [TBL] [Abstract][Full Text] [Related]
18. The potential role of RNA N6-methyladenosine in Cancer progression. Wang T; Kong S; Tao M; Ju S Mol Cancer; 2020 May; 19(1):88. PubMed ID: 32398132 [TBL] [Abstract][Full Text] [Related]
19. Malignant Evaluation and Clinical Prognostic Values of m6A RNA Methylation Regulators in Glioblastoma. Du J; Hou K; Mi S; Ji H; Ma S; Ba Y; Hu S; Xie R; Chen L Front Oncol; 2020; 10():208. PubMed ID: 32211315 [TBL] [Abstract][Full Text] [Related]
20. Recent advances of m6A methylation in skeletal system disease. Liang J; Yi Q; Liu Y; Li J; Yang Z; Sun W; Sun W J Transl Med; 2024 Feb; 22(1):153. PubMed ID: 38355483 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]